| abstract |
The present invention relates to novel oxazolidinones having a cyclopropyl moiety which are effective above aerobic and anaerobic pathogens such as multiresistant staphylococci, stieptococci, Bacteroides spp., Clostridia spp., Species, as well as acid-resistant organisms such as the Mycobacterium tuberculosis and other The compounds are represented by structural formula: (I): its enantiomer, diastereomer or pharmaceutically acceptable salts or esters thereof. |